z-logo
open-access-imgOpen Access
Early, Subacute Coronary Stent Thrombosis: A Complication of COVID-19 Infection
Author(s) -
Tabatabai Sadeq,
Bazargani Nooshin,
Al-Tahmody Kamaleldin,
Alhashmi Jasem Mohammed
Publication year - 2021
Publication title -
dubai medical journal
Language(s) - English
Resource type - Journals
ISSN - 2571-726X
DOI - 10.1159/000520461
Subject(s) - educational corner – case report
Soon after it was discovered in Wuhan, China, in December 2019, coronavirus disease 2019 (COVID-19) blow-out very fast and became a pandemic. The usual presentation is respiratory tract infection, but cardiovascular system involvement is sometimes fatal and also a serious personal and health care burden. We report a case of a 57-year-old man who was admitted with anterior wall acute myocardial infarction secondary to early coronary stent thrombosis and associated with COVID-19 infection. He was managed with primary coronary angioplasty and discharged home. Procoagulant and hypercoagulability status associated with severe acute respiratory syndrome coronavirus 2 infection is the most likely culprit. Choosing aggressive antithrombotic agents after coronary angioplasty to prevent stent thrombosis during the COVID-19 pandemic may be the answer but could be challenging.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here